Hamberg, P., Steeghs, N., Loos, W. J., van de Biessen, D., den Hollander, M., Tascilar, M., . . . Sleijfer, S. (2010). Decreased exposure to sunitinib due to concomitant administration of ifosfamide: Results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies. Nature Publishing Group.
Citación estilo ChicagoHamberg, P., N. Steeghs, W J. Loos, D. van de Biessen, M. den Hollander, M. Tascilar, J. Verweij, H. Gelderblom, y S. Sleijfer. Decreased Exposure to Sunitinib Due to Concomitant Administration of Ifosfamide: Results of a Phase I and Pharmacokinetic Study On the Combination of Sunitinib and Ifosfamide in Patients With Advanced Solid Malignancies. Nature Publishing Group, 2010.
Cita MLAHamberg, P., et al. Decreased Exposure to Sunitinib Due to Concomitant Administration of Ifosfamide: Results of a Phase I and Pharmacokinetic Study On the Combination of Sunitinib and Ifosfamide in Patients With Advanced Solid Malignancies. Nature Publishing Group, 2010.